Continuing our FREE Educational Webinar series:
Managing #Cardiovascular Risk in the Community

'Modern treatment of Type 2 diabetes - when to use SGLT2 inhibitors, DPP-4 inhibitors and GLP-RAs'
🗣️Prof @milesfisher2

📅26 May 2022


Thank you at @SHARPScotland for a fantastic hybrid meeting!

Lots to consider from a patient perspective! #BigData 💥 #DigitalHealth #Wearables #SGLT2 #DOAC

🎯 Important to translate this science to the patients on the ground

Many thanks to all contributors 🫀😊

The SHARP & @ScotLipidForum Hybrid Meeting for 2021 at the @RCPEdin comes to a close.

Thank you to all who attended, both in person and online.

We look forward to welcoming you back next year!

Load More...